# Cross-Symbol Breadth Acceleration Phase 1.5

## Scope
- This is a near-miss lead diagnostic, not strategy development.
- It does not modify entries, formal strategies, demo runners, live runners, or API keys.
- `research_asset` does not mean tradable policy.

## Required Answers
1. Why keep looking? It is the only candidate with train/validation/oos no-cost positive and high direction_match; no-cost positive all splits=true.
2. Why not stable? control_robustness;concentration_repair_non_disastrous;top_trade_dependency_controllable;funding_not_primary_source.
3. OOS cost-aware -13.86 marginal or structural? marginal_execution_fragile.
4. Funding-adjusted positive depends on funding? true.
5. Can concentration_fail be repaired? false.
6. Is top-trade dependency healthy? false.
7. Is there a signal-strength plateau? true.
8. Is there an earlier breadth trigger? true.
9. Is it significantly better than random/reverse? false.
10. Upgrade to research_asset? false.
11. Strategy development allowed? false.
12. Demo/live allowed? false.

## Decision
- research_asset=false
- recommended_next_step=pause_or_new_hypothesis
- strategy_development_allowed=false
- demo_live_allowed=false
